These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34513896)

  • 1. The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Wongtrakul W; Niltwat S; Charatcharoenwitthaya P
    Front Med (Lausanne); 2021; 8():744713. PubMed ID: 34513896
    [No Abstract]   [Full Text] [Related]  

  • 2. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
    Dunn W; Sanyal AJ; Brunt EM; Unalp-Arida A; Donohue M; McCullough AJ; Schwimmer JB
    J Hepatol; 2012 Aug; 57(2):384-91. PubMed ID: 22521357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Aby ES; Panjawatanan P; Lapumnuaypol K; Cheungpasitporn W; Lukens FJ; Harnois DM; Ungprasert P
    Ann Gastroenterol; 2021; 34(4):568-574. PubMed ID: 34276197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.
    Magherman L; Van Parys R; Pauwels NS; Verhelst X; Devisscher L; Van Vlierberghe H; Geerts A; Lefere S
    Aliment Pharmacol Ther; 2023 Apr; 57(8):820-836. PubMed ID: 36708129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.
    Mitchell T; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Ching H; Hamdorf J; Adams LA
    Am J Gastroenterol; 2018 Oct; 113(10):1484-1493. PubMed ID: 29899440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Koutoukidis DA; Koshiaris C; Henry JA; Noreik M; Morris E; Manoharan I; Tudor K; Bodenham E; Dunnigan A; Jebb SA; Aveyard P
    Metabolism; 2021 Feb; 115():154455. PubMed ID: 33259835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
    Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
    Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
    Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.
    Kwon HK; Greenson JK; Conjeevaram HS
    Liver Int; 2014 Jan; 34(1):129-35. PubMed ID: 23809459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.
    Blomdahl J; Nasr P; Ekstedt M; Kechagias S
    Metabolism; 2021 Feb; 115():154439. PubMed ID: 33246008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.
    Kositamongkol C; Kanchanasurakit S; Auttamalang C; Inchai N; Kabkaew T; Kitpark S; Chaiyakunapruk N; Duangjai A; Saokaew S; Phisalprapa P
    Front Pharmacol; 2021; 12():786596. PubMed ID: 34966282
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of alcohol consumption on nonalcoholic fatty liver disease.
    Weng G; Dunn W
    Transl Gastroenterol Hepatol; 2019; 4():70. PubMed ID: 31620652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study.
    Hajifathalian K; Torabi Sagvand B; McCullough AJ
    Hepatology; 2019 Aug; 70(2):511-521. PubMed ID: 30125379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis.
    Singh A; Hussain S; Antony B
    Diabetes Metab Syndr; 2021; 15(3):813-822. PubMed ID: 33862417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
    Johnston MP; Patel J; Byrne CD
    Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
    Li J; Zou B; Yeo YH; Feng Y; Xie X; Lee DH; Fujii H; Wu Y; Kam LY; Ji F; Li X; Chien N; Wei M; Ogawa E; Zhao C; Wu X; Stave CD; Henry L; Barnett S; Takahashi H; Furusyo N; Eguchi Y; Hsu YC; Lee TY; Ren W; Qin C; Jun DW; Toyoda H; Wong VW; Cheung R; Zhu Q; Nguyen MH
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):389-398. PubMed ID: 30902670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
    Kimura T; Tanaka N; Fujimori N; Sugiura A; Yamazaki T; Joshita S; Komatsu M; Umemura T; Matsumoto A; Tanaka E
    World J Gastroenterol; 2018 Apr; 24(13):1440-1450. PubMed ID: 29632425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
    Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.